In environments where software influences real clinical decisions, rigor is not optional. It is the condition that makes ...
Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories, ...
Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix") (CSE: BLO) (OTCID: BLOZF) announce the development and validation of ...
MAIA recently announced that it has completed international enrollment in Part C of the Phase 2 THIO-101 expansion trial. Treatment with ateganosine followed by cemiplimab has shown an acceptable ...
According to Future Market Insights (FMI), the global home sleep apnea testing market is projected to grow from USD 734.4 million in 2026 to USD 996.6 ...
The war between the U.S.-Israel and Iran, which raged until this past May, left several countries in the Gulf region—such as ...
When will you receive it on your mobile phone and why? - The alert will be sent to nearly 90 million UK devices later this year ...
“All I did was ask for a review because I didn’t think it was a foul,” United States President Donald Trump said this week in front of reporters in the Oval Office. He was explaining why he had ...
Code generation is emerging as one of the most popular applications for large language models (LLMs), but not all agents are ...
Many ideas struggle to make the leap from abstract thought to practical application. Sometimes this is because they are ...
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
Co-Diagnostics, Inc. ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results